Select Publications
Journal articles
2007, 'Highly endemic hepatitis B infection in rural Vietnam', Journal of Gastroenterology and Hepatology, 22, pp. 2093 - 2100
,2007, 'Identification of a novel hepatitis B virus precore/core deletion mutant in HIV-1/hepatitis B virus co-infected individuals.', AIDS, 21, pp. 1701 - 1710
,2007, 'Improved cognitive function as a consequence of hepatitis C virus treatment', HIV Medicine, 8, pp. 520 - 528
,2007, 'Improvements in parameters of end-stage liver disease in patients with HIV/HBV-related cirrhosis treated with tenofovir', Antiviral Therapy, 12, pp. 119 - 122
,2007, 'Liver cancer and hepatitis B and C in New South Wales, 1990-2002: a linkage study', Australian and New Zealand Journal of Public Health, 31, pp. 475 - 482
,2007, 'Low incidence of HCV reinfection: Exposure, testing frequency, or protective immunity?', Hepatology, 45, pp. 1330 - 1330
,2007, 'Modelling the hepatitis C virus epidemic in Australia', Drug and Alcohol Dependence, 91, pp. 228 - 235, http://dx.doi.org/10.1016/j.drugalcdep.2007.05.026
,2007, 'Potential biases in estimates of hepatitis C RNA clearance in newly acquired hepatitis C infection among a cohort of injecting drug users', Epidemiology and Infection, 135, pp. 144 - 150
,2007, 'Predictors of completion of a hepatitis Bvaccination schedule in attendees at a primary health care centre.', Sexual Health, 4, pp. 27 - 30
,2007, 'Prevalence and risk factors for hepatitis C infection in rural north Vietnam.', Hepatol Int, 1, pp. 387 - 393
,2007, 'Recruitment and follow-up of injecting drug users in the setting of early hepatitis C treatment: Insights from the ATAHC study', International Journal of Drug Policy, 18, pp. 447 - 451, http://dx.doi.org/10.1016/j.drugpo.2007.01.007
,2007, 'Referral for chronic hepatitis C treatment from a drug dependency treatment setting', Drug and Alcohol Dependence, 88, pp. 49 - 53
,2007, 'Response to Schmutz et al., `Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapv of hepatitis B in HIV-coinfection`', AIDS, 21, pp. 777 - 778
,2007, 'The 2004 Australian prison entrants` blood-borne virus and risk behaviour survey', Australian and New Zealand Journal of Public Health, 31, pp. 44 - 50
,2007, 'Treatment of recently acquired hepatitis C infection in injecting drug users: Preliminary results from the Australian trial in acute hepatitis C (ATAHC)', Hepatology, 46, pp. 358A - 358A
,2006, 'Mortality in patients with hepatitis B or hepatitis C - Authors' reply', Lancet, 368, pp. 1767, http://dx.doi.org/10.1016/S0140-6736(06)69729-8
,2006, 'Results of a phase 1B, multiple dose study of R1626, a novel nucleoside analog targeting HCV polymerase in chronic HCV genotype 1 patients', Hepatology, 44, pp. 692A - 692A, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000241362302442&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
,2006, 'Cancer incidence in people with hepatitis B or C infection: A large community-based linkage study', Journal of Hepatology, 45, pp. 197 - 203
,2006, 'Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study', Lancet, 368, pp. 938 - 945
,2006, 'Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy', AIDS, 20, pp. 863 - 870
,2006, 'HAART`s first decade: success brings further challenges', Lancet, 368, pp. 427 - 428
,2006, 'Hepatitis C in Australia: impact of a mass media campaign', American Journal of Preventive Medicine, 31, pp. 492 - 498, http://dx.doi.org/10.1016/j.amepre.2006.08.001
,2006, 'Management of chronic hepatitis B in challenging patient populations.', Liver International, 26, pp. 38 - 46
,2006, 'Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies', Journal of Viral Hepatitis, 13, pp. 34 - 41
,2006, 'The effect of hepatitis C virus infection on health-related quality of life in prisoners', Journal of Urban Health - Bulletin of the New York Academy of Medicine, 83, pp. 275 - 288
,2005, 'Cancer incidence in people with hepatitis B or C infection: A population based cohort study', Journal of Hepatology, 42, pp. 88 - 88, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000229024000228&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
,2005, 'Estimation of utilities for chronic hepatitis C from SF-36 scores', American Journal of Gastroenterology, 100, pp. 643 - 651
,2005, 'Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapy', Journal of Gastroenterology and Hepatology, 20, pp. 1082 - 1086
,2005, 'HIV disease progression in a patient cohort treated via a clinical research network in a resource limited setting', AIDS, 19, pp. 169 - 178
,2005, 'Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia', Clinical Infectious Diseases, 40, pp. S313 - S320
,2005, 'Management and treatment of injection drug users with hepatitis C virus(HCV) infection and HCV/human immunodeficiency virus coinfection', Seminars in Liver Disease, 25, pp. 18 - 32
,2005, 'Prevalence and risk factors of hepatitis C in HIV-negative homosexual men in Sydney, Australia', Australian and New Zealand Journal of Public Health, 29, pp. 536 - 539
,2005, 'The impact of injecting drug use status on hepatitis C-related referral and treatment', Drug and Alcohol Dependence, 77, pp. 81 - 86, http://www.sciencedirect.com/science/article/B6T63-4D99DYG-1/2/42ceb60f2196a4dcc220b7c3ec818c86
,2005, 'Treatment for hepatitis C virus infection among current injection drug users in Australia', Clinical Infectious Diseases, 40, pp. S325 - S329
,2004, 'Editorial comment: Triple infection with HIV and hepatitis B and C viruses - Lesson in combination therapy', AIDS Reader, 14, pp. 392
,2004, 'Clearance of hepatitis C virus after newly acquired infection ininjection drug users', Journal of Infectious Diseases, 190, pp. 1270 - 1274
,2004, 'Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and -experienced patients coinfected with HIV-1 and hepatitis B virus', Journal of Infectious Diseases, 189, pp. 1185 - 1192
,2004, 'Estimates of chronic hepatitis B virus infection in Australia, 2000', Australian and New Zealand Journal of Public Health, 28, pp. 212 - 216
,2004, 'Estimates of chronic hepatitis B virus infection in Australia, 2000', Australian and New Zealand Journal of Public Health, 28, pp. 212 - 216, http://dx.doi.org/10.1111/j.1467-842x.2004.tb00477.x
,2004, 'Global burden of disease (GBD) for hepatitis C', Journal of Clinical Pharmacology, 44, pp. 20 - 29
,2004, 'Hepatitis C prevalence - a nationwide serosurvey', Annual report of the Australian Meningococcal Surveillance Programme, 2007--Amended, 28, pp. 517 - 521
,2004, 'Hepatitis C virus incidence among injecting drug users on opioid replacement therapy', Australian and New Zealand Journal of Public Health, 28, pp. 576 - 578
,2004, 'HIV and hepatitis C coinfection within the CAESAR study', HIV Medicine, 5, pp. 174 - 179
,2004, 'Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort', AIDS, 18, pp. 1169 - 1177
,2004, 'Long-term outcome of vertically acquired and post-transfusion hepatitis C infection in children', Journal of Gastroenterology and Hepatology, 19, pp. 1357 - 1362
,2004, 'Severe diverticulitis after heart, lung, and heart-lung transplantation', Journal of Heart and Lung Transplantation, 23, pp. 845 - 849
,2004, 'Surveillance for newly acquired hepatitis C in Australia', Journal of Gastroenterology and Hepatology, 19, pp. 283 - 288
,2003, 'Response to Soriano et al., 'Treatment of chronic hepatitis C virus infection: We must target the virus or liver fibrosis?' [3]', AIDS, 17, pp. 2675 - 2676
,2003, 'Cost-effectiveness of treatment for chronic hepatitis C infection', JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 290, pp. 1993 - 1993, http://dx.doi.org/10.1001/jama.290.15.1993-b
,2003, 'Cost-effectiveness of Treatment for Chronic Hepatitis C Infection [2] (multiple letters)', JAMA, 290, pp. 1993 - 1994, http://dx.doi.org/10.1001/jama.290.15.1993-a
,